Citizens Financial Group Inc Pfizer Inc Transaction History

Citizens Financial Group Inc

$4.91 Billion
Q3 2024

A detailed history of Citizens Financial Group Inc transactions in Pfizer Inc stock. As of the latest transaction made, Citizens Financial Group Inc holds 304,477 shares of PFE stock, worth $8.14 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

304,477

Previous 200,310 52.0%

Holding current value

$8.14 Million

Previous $5.6 Million 57.23%

% of portfolio

0.18%

Previous 0.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$27.7 - $31.39 $2.89 Million - $3.27 Million	104,167 Added 52.0%	304,477 $8.81 Million
Q2 2024 Aug 09, 2024	BUY	$25.26 - $29.6 $1.96 Million - $2.3 Million	77,780 Added 63.48%	200,310 $5.6 Million
Q1 2024 May 17, 2024	SELL	$25.89 - $29.73 $606,835 - $696,841	-23,439 Reduced 16.06%	122,530 $3.4 Million
Q4 2023 Feb 02, 2024	BUY	$26.13 - $33.94 $1.1 Million - $1.43 Million	42,202 Added 40.67%	145,969 $4.2 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $368,072 - $430,239	-11,470 Reduced 9.95%	103,767 $3.44 Million
Q2 2023 Aug 04, 2023	SELL	$36.12 - $41.79 $518,502 - $599,895	-14,355 Reduced 11.08%	115,237 $4.23 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $209,791 - $273,117	5,326 Added 4.29%	129,592 $5.29 Million
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $59,076 - $77,117	1,415 Added 1.15%	124,266 $6.37 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $24,724 - $30,182	-565 Reduced 0.46%	122,851 $5.38 Million
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $263,173 - $312,041	5,656 Added 4.8%	123,416 $6.47 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $79,056 - $97,960	-1,728 Reduced 1.45%	117,760 $6.1 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $909 - $1,347	22 Added 0.02%	119,488 $6.95 Million
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $1.69 Million - $2.17 Million	42,957 Added 56.15%	119,466 $5.14 Million
Q2 2021 Aug 04, 2021	BUY	$35.91 - $40.68 $300,458 - $340,369	8,367 Added 12.28%	76,509 $3 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $12,123 - $13,672	362 Added 0.53%	68,142 $2.47 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $107,237 - $136,362	-3,204 Reduced 4.51%	67,780 $2.5 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $211,074 - $247,638	-6,648 Reduced 8.56%	70,984 $2.6 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $39,457 - $47,867	-1,310 Reduced 1.66%	77,632 $2.54 Million
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $17,677 - $25,257	654 Added 0.84%	78,942 $2.58 Million
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $204,795 - $232,416	-6,221 Reduced 7.36%	78,288 $3.07 Million
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $5.66 Million - $7.34 Million	-174,114 Reduced 67.32%	84,509 $3.04 Million
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $275,353 - $309,157	-7,446 Reduced 2.8%	258,623 $11.2 Million
Q1 2019 May 09, 2019	BUY	$37.5 - $41.2 $276,337 - $303,602	7,369 Added 2.85%	266,069 $11.3 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $42,817 - $48,816	-1,113 Reduced 0.43%	258,700 $11.3 Million
Q3 2018 Nov 02, 2018	BUY	$34.47 - $41.81 $5.53 Million - $6.71 Million	160,423 Added 161.41%	259,813 $11.5 Million
Q2 2018 Jul 27, 2018	SELL	$32.98 - $35.16 $288,838 - $307,931	-8,758 Reduced 8.1%	99,390 $3.61 Million
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $171,165 - $198,575	-5,364 Reduced 4.73%	108,148 $3.84 Million
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $323,752 - $343,512	-9,734 Reduced 7.9%	113,512 $4.11 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $100,161 - $110,338	3,231 Added 2.69%	123,246 $4.4 Million
Q2 2017 Aug 10, 2017	BUY	N/A	120,015	120,015 $4.03 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.

Account

Citizens Financial Group Inc Pfizer Inc Transaction History